Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8785316 | Brachytherapy | 2018 | 7 Pages |
Abstract
The relapse pattern after a single 19-Gy HDR-BT is predominantly associated with the site of initial disease. This lends some rationale to future strategies of further focused dose escalation to initial site of disease, notwithstanding the fact that the calculated biologically equivalent dose using linear-quadratic assumptions is already very high.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Lucas C. Mendez, Ananth Ravi, Hans Chung, Chia-Lin Tseng, Matt Wronski, Moti Paudel, Merrylee McGuffin, Patrick Cheung, Andrew Loblaw, Gerard Morton,